Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
-
Asian markets rise as US rate cut bets temper Japan bond unease
-
Weight of history against England in pink-ball Gabba Ashes Test
-
How South Korea's brief martial law upended lives
-
VR headsets take war-scarred children to world away from Gaza
-
'We chose it': PKK fighters cherish life in Iraq's mountains
-
US envoy to meet Russia's Putin for talks on ending Ukraine war
-
Pope Leo holds Beirut mass and visits site of port blast
-
'Quad God' Malinin ramps up Olympic preparations at Grand Prix Final
-
New Zealand 17-1 at lunch in rain-hit West Indies Test
-
Pacific island office enabling sanctions-busting 'shadow fleets'
-
White House gets scaled-down Christmas display amid ballroom work
-
Son of Mexican crime lord 'El Chapo' pleads guilty in drug case
-
White House confirms admiral ordered 2nd strike on alleged drug boat
-
Nigeria's defence minister resigns amid security crisis: presidency
-
From Honduras to Poland, Trump meddles in elections as never before
-
Trump holds Venezuela meeting as Maduro rejects 'slave's peace'
-
12 dead, dozens missing as landslide submerges boats in Peru port
-
Vardy's first Serie A double fires Cremonese past high-flying Bologna
-
Rich art: French pastry chefs auction chocolate sculptures
-
Cameroon sack coach Brys, drop goalkeeper Onana for AFCON
-
Son of Mexican crime lord 'El Chapo' pleads guilty in drug case: US media
-
Right-wing rivals for Honduras presidency in 'technical tie'
-
US upbeat on pushing Ukraine deal as envoy heads to Russia
-
European rocket puts S.Korean satellite in orbit
-
Trump to meet top national security team on Venezuela
-
US Supreme Court hears major online music piracy case
-
Pope gets rockstar welcome as he delivers message of hope to Lebanese youth
-
Iran sentences director Jafar Panahi to year in prison: lawyer
-
ICC vows to stand firm amid US sanctions
-
Ukraine's Zelensky eyes Trump talks after 'progress'
-
US to zero out tariffs on UK pharma under trade deal
-
Chelsea captain James says 10-man Blues 'dominated' Arsenal
-
In contrast to Europe, Tesla sets sales records in Norway
-
Asia floods death toll tops 1,160 as troops aid survivors
-
DR Congo says latest Ebola outbreak is over
-
South Africa coach Broos picks 17 local stars for AFCON
-
Murray 'disappointed' with results coaching former rival Djokovic
-
Bulgaria hosts opening trio of 2026 Giro stages
-
Pope urges Lebanon's religious leaders to fight intolerance
-
Hong Kong arrests suspects as fire death toll tops 150
-
Red Bull apologise for criticism after Antonelli receives death threats
-
The far right's 'accelerated' rise in Croatia
-
Twice-a-year HIV prevention shots begin in Africa
-
Trump-backed conservative holds knife-edge lead in Honduras vote
-
Man City boss Guardiola uncertain over Rodri return
-
WHO backs GLP-1 treatments to tackle obesity epidemic
-
Stocks turn lower as traders eye US data for Fed signals
-
Barca's Flick happy to have players back for Atletico clash
-
How Paris's oldest bridge will become an 'immersive cave'
-
Ukraine conflict hits Napoleonic war re-enactment in Belarus
NYSE - LSE
| RBGPF | -0.42% | 76 | $ | |
| SCS | 0.55% | 16.38 | $ | |
| CMSD | -0.13% | 23.29 | $ | |
| GSK | -1.42% | 47.19 | $ | |
| NGG | -0.61% | 75.65 | $ | |
| BP | 1.12% | 36.51 | $ | |
| RIO | 0.03% | 71.97 | $ | |
| AZN | -2.44% | 90.52 | $ | |
| BTI | -0.91% | 58.13 | $ | |
| CMSC | -0.39% | 23.32 | $ | |
| RELX | -1.23% | 39.72 | $ | |
| BCE | -0.09% | 23.49 | $ | |
| BCC | -1.18% | 75.13 | $ | |
| JRI | -0.15% | 13.78 | $ | |
| RYCEF | 1.38% | 13.8 | $ | |
| VOD | -2.8% | 12.13 | $ |
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
DENVER, CO / ACCESS Newswire / November 24, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that its management will participate at NobleCon21 - Noble Capital Markets' 21st Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL.
Management will be presenting on Wednesday, December 3rd at 10:30 a.m. Eastern time. A high-definition video webcast of the presentation will be available the following day on the Company's website (www.aytubio.com), and as part of a complete catalog of presentations available at Noble Capital Markets' Conference website (www.nobleconference.com) and on Channelchek (www.channelchek.com), the investor portal created by Noble. The webcast will be archived on the Company's website, the NobleCon website and on Channelchek for 90 days following the event.
Management will also be conducting one-on-one meetings at the conference. Investors should contact their Noble representatives, or Robert Blum of Lytham Partners at [email protected], to schedule one-on-one meetings.
About Aytu BioPharma
Aytu is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. The Company's prescription products include EXXUA™ (gepirone) extended-release tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of major depressive disorder (MDD) and treatments for attention deficit-hyperactivity disorder (ADHD). Aytu is committed to delivering the Company's medications through best-in-class patient access programs that help to enable optimal patient outcomes. For more information, please visit aytubio.com or follow us on LinkedIn.
Contacts for Investors
Ryan Selhorn, Chief Financial Officer
Aytu BioPharma, Inc.
[email protected]
Robert Blum
Lytham Partners
[email protected]
SOURCE: Aytu BioPharma, Inc.
View the original press release on ACCESS Newswire
G.Stevens--AMWN